Sigma’s perspective is shaped by hands-on clinical, translational, and operational experience. We help bridge innovation, physician insight, and development strategy across the product lifecycle.
Connect product strategy to real physician workflows and adoption needs.
Support development decisions with practical medical and market context.
Harmonizing every phase of the development lifecycle to mitigate regulatory, clinical, budget, and timeline risks.
We support Class II and III device programs requiring strong translational alignment from development through market readiness.
Diagnostic technologies demand early integration of clinical utility, regulatory classification, and validation strategy.
AI-enabled technologies represent a new area of MedTech requiring delicate regulatory navigation and lifecycle governance.
As former directors and executives of mid to large-size CROs, we are able to effectively advise and guide Sponsors through:
We support market-facing strategies that strengthen adoption, reimbursement, lifecycle evidence, and long-term growth.
